semaglutide expectations Tirzepatide vs. for Weight Loss How Long Does Semaglutide Take

Materials and Methods Mean percent change in weight from baseline, weight reduction 5% and mean change in glycated haemoglobin (HbA1c [%]) were compared between tirzepatide 10/15 mg (week 72, SURMOUNT2) and semaglutide 2.4 mg (week 68, STEP 2) applying the Bucher method to the efficacy estimand

398 [41%] women) were included

Prof Gs answer Q: The evidence regarding GLP-1 use and safety in people with MS YES Q: Whether the metabolic benefits alone justify considering them in someone with my profile YES For information on why I am saying yes and yes, the following is a more detailed discussion on the evidence of the therapeutic potential of GLP-1 receptor agonists in MS and what I think about the HCPs attitudes to your requests.

Primary indication: Rybelsus is FDA-approved to manage blood sugar levels in people with type 2 diabetes